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Introduction 
What is Cardiogenic 
Shock? 
• Cardiogenic shock is defined as a 
state in which ineffective cardiac 
output leads to inadequate tissue 
perfusion (van Diepen et al., 2017). 
• Defining characteristics include: 
• Hypotension 




(Brener et al., 2020) 
• Acute Myocardial Infarction (AMI) 
with left ventricular dysfunction is 
the leading cause of cardiogenic 
shock in the United States. 
(Mandawat & Rao, 2017) 
“Potential hemodynamic presentations of cardiogenic shock. 
CI indicates cardiac index; PCWP, pulmonary capillary wedge pressure; and SVRI, 
systemic vascular resistance index” (Van Diepen et al., 2017, p. 235). 
“Physical findings suggestive of the ventricle primarily involved in cardiogenic 
shock. Both sides often contribute to the clinical presentation and physical exam 
findings” (Vahdatpour et al., 2019, p.3). 
Why Cardiogenic Shock? 
(Brener et al., 2020) 
• Despite advances in modern medicine, mortality in patients with acute myocardial infarction complicated by 
cardiogenic shock is approximately 50% (Shah et al., 2019). 
• In contrast to other acute cardiac conditions, cardiogenic shock does not have precise evidence-based practice 
protocols that improve outcomes and lacks definitive treatment strategies (Uhlig et al., 2020). 
• Continued research is necessary to advance current clinical practices and treatment options (Shah et al., 2019). 
Clinicians who manage patients with cardiogenic shock must be aware of the complexities involved. 
Pathophysiological Processes 
Signs and Symptoms 
1. Hemodynamic Criteria: 
• Systolic blood pressure (SBP) <90 
mmHg for greater than 30 minutes 
• Use of vasopressors or inotropic 
support to maintain SBP >90 mmHG 
• Reduced cardiac output, 2.0-2.2 
L/min/m2 with vasopressor and/or 
inotropic support 
(Shah et al. ,2019) 
2. Signs of end-organ hypoperfusion 
• Tachycardia 
• Low urine output 
• Altered mental status 
• Pale, cool, clammy peripheries 
• Increase lactate levels 
• Low mixed venous saturation 
(<65%) 
• Shortness of breath 
(Shah et al. ,2019) 
Underlying 
Pathophysiology 
• Acute myocardial infarction 
(AMI) accounts for 80% of 
cardiogenic shock cases 
(Brener et al., 2020) 
• Cardiac ischemia secondary 
to AMI causes left ventricular 
dysfunction/failure and 
decreased cardiac stroke 
volumes (van Diepen et al., 
2017) 
• Diminished cardiac output 
and hypotension refractory to 
fluid resuscitation lead to 
tissue hypoperfusion and 
ischemia (Vahdatpour et al., 
2019) 
• Tissue ischemia causes 
compensatory peripheral 
vasoconstriction that 
increases cardiac workload 
and worsens cardiac ischemia 
(Vahdatpour et al., 2019) 
• Compensatory catecholamine 
release to stimulate cardiac 
contractility causes further 
stress upon the damaged 
myocardium (Vahdatpour et 
al., 2019) 
• Increased cardiac workload 
and stress potentiates cardiac 
injury and ischemia causing 
worsened shock state ( 
• Noncoronary related 
myocardial injury to valves, 
pericardium, or electrical 
pathways can also lead to 
impaired cardiac function and 
cardiogenic shock (Brener et 
al., 2020) 
• Chronic heart failure (CHF) 
with acute decompensation 
may also present in 
cardiogenic shock state 
• In CHF, chronic upregulation 
of renin-angiotensin-
aldosterone system causes 
ventricular hypertrophy 
leading to cardiac dysfunction 
Significance of Pathophysiology 
The cyclical nature of cardiogenic shock leads to progressive cardiac dysfunction 
and worsened cardiac and tissue ischemia (Shah et al., 2019) In normal cardiac 
physiology, the supply and demand of oxygen to the heart and body is 
autoregulated by multiple compensatory mechanisms. In cardiogenic shock, 
homeostasis is disrupted and compensatory mechanisms such as peripheral 
vasoconstriction and catecholamine release cause increased myocardial demand 
which worsens primary insult to the heart (Vahdatpour et al., 2019). Continued 
and worsening damage of heart tissue exacerbates cardiac dysfunction causing 
vital end-organ failure and high mortality rates (Shah et al., 2019) 
Treatment 
• Treatment of cardiogenic shock focuses on treating/reversing the underlying 
causative process and supportive therapies 
• Coronary reperfusion and revascularization for acute myocardial infarction 
related cardiogenic shock (van Diepen et al., 2017) 
• Supportive therapies include: 
• Oxygen administration and mechanical ventilation (Vahdatpour et al., 
2019) 
• Medication and/ or mechanical blood pressure support (Uhlig et al., 2020) 
• Mechanical support devices include: 
• Inta-aortic balloon pump (IABP) 
• Impella 
• Vascular assistive device (VAD) 
• Extracorporeal membrane oxygenation 
(ECMO) 
• Tandemheart 
• Fluid resuscitation with goal of euvolemia (Shah et al., 2019) 
• Frequent monitoring of intra-cardiac pressures is recommended with the use of 
pulmonary artery catheter (Brener et al., 2020) 
Implications for 
Nursing Care 
• Admission to critical care unit is 
essential to treat and monitor 
hemodynamic instability in 
addition to general critical care 
interventions (Shah et al., 2019) 
• Early identification and 
treatment of cardiogenic shock 
are paramount to the success of 
interventions (Mandawat & Rao, 
2017) 
• Models of care should include a 
multidisciplinary care team 
specifically designated for 
patients with cardiogenic shock 
(van Diepen et al., 2017) 
• Tertiary care centers with 
cardiac specialists should be 
utilized as they have the 
expertise and resources 
available to treat the 
complexities of cardiogenic 
shock (van Diepen et al., 2017) 
Conclusion 
• Cardiogenic shock is a complex 
state of hypotension and low 
cardiac output leading to tissue 
hypoperfusion (Brener et al., 
2020) 
• Treatment of the cyclical nature 
of cardiogenic shock is focused 
on fixing the underlying issue 
and supportive therapies (van 
Diepen et al., 2017) 
• Further research is necessary to 
understand cardiogenic shock 
and evaluate evidence-based 
interventions that improve the 
high mortality rates of 
cardiogenic shock (Uhlig et al., 
2020) 
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